# Biomarker Study in Pancreatic Neuroendocrine Tumours

> **NCT03130205** · — · UNKNOWN · sponsor: **Uppsala University** · enrollment: 30 (estimated)

## Conditions studied

- Neuroendocrine Tumors

## Interventions

- **PROCEDURE:** Core Needle Biopsy
- **RADIATION:** Computed Tomography
- **RADIATION:** 18F-FDG-PET
- **PROCEDURE:** Phlebotomy
- **GENETIC:** Molecular genetic analysis

## Key facts

- **NCT ID:** NCT03130205
- **Lead sponsor:** Uppsala University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-05-01
- **Primary completion:** 2021-01-01
- **Final completion:** 2022-01-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2017-08-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03130205

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03130205, "Biomarker Study in Pancreatic Neuroendocrine Tumours". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03130205. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*